.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Union Health Ministry has officially launched a nationwide HPV vaccination campaign to combat the high burden of cervical cancer in India. Consequently, the government aims to vaccinate approximately 1.15 crore girls aged 14 years every year across all states. This initiative aligns with the 'Swastha Nari' vision, focusing on protection and equity in women's healthcare. Therefore, the vaccine will be available free of cost at various government health facilities, including Ayushman Arogya Mandirs and district hospitals.
During the initial three-month mission mode phase, eligible girls can receive the vaccine daily at designated centers. Furthermore, the program will transition into routine immunization schedules after this intensive period. It is important to note that vaccination is voluntary. Thus, healthcare providers must obtain informed consent from parents or guardians before administration. Additionally, every session will have supervision from trained medical officers to ensure safety.
The campaign utilizes the Gardasil 4 vaccine, which is a quadrivalent option protecting against HPV types 6, 11, 16, and 18. Specifically, types 16 and 18 cause over 80% of cervical cancer cases in India. Clinical evidence suggests that these vaccines are highly effective. For instance, studies show 93-100% effectiveness in preventing cervical cancer caused by these specific types. Moreover, India has adopted a single-dose schedule for this rollout. This decision follows recommendations from the World Health Organization and India's National Technical Advisory Group on Immunisation.
Scientific data confirms that a single dose provides protection comparable to multi-dose schedules for girls aged 9-20. Because of this, more than 90 countries have already moved to single-dose protocols to improve coverage and affordability. India now joins over 160 nations that have integrated HPV vaccination into their national programs. Meanwhile, the government has secured supplies through a transparent mechanism with GAVI to ensure uninterrupted availability across the country.
Q1: Who is the primary target group for this vaccination drive?
The campaign primarily targets girls aged 14 years across all states and Union territories in India.
Q2: Is the HPV vaccine being provided as a single dose or double dose?
India is implementing a single-dose schedule of the Gardasil 4 vaccine, following WHO and NTAGI recommendations for this age group.
Q3: Where can eligible girls receive the vaccine?
Vaccines are available for free at government medical colleges, district hospitals, community health centers, and Ayushman Arogya Mandirs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Indian government has launched a nationwide HPV vaccination drive targeting 1.15 crore girls aged 14 annually to reduce cervical cancer incidence....
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
